.png){kind=logo}
- Insights
- Cryptocurrencies
- Stocks
- White Papers
- Industry
- Geography
- Insights
- Cryptocurrencies
- Stocks
- White Papers
- Industry
- Geography
Similar to other industries, artificial intelligence (AI) is transforming the healthcare sector in a variety of ways. Artificial intelligence has the potential to improve the speed, effectiveness, and efficiency of global health systems. The global revenue of artificial intelligence in the healthcare market will be driven by the rising number of patient data sets and the rising demand for lower healthcare costs. Applications such as radiology, patient risk identification, drug discovery, and diagnosis, to name a few, have all been transformed by AI, which has been a game-changer in the healthcare industry. Recent AI in healthcare trends such as drug design, data mining, and surgical robots are also transforming the industry's growth.
The introduction of artificial intelligence into healthcare has been accelerated by COVID-19. Solutions and services based on AI can respond quickly, on a large scale, and to the crisis's dynamic nature. Artificial intelligence was a crucial component that assisted the healthcare sector during the pandemic. The World Health Organization (WHO) indicated that artificial intelligence (AI) could be a crucial technology for managing the coronavirus-caused crisis as soon as the pandemic was announced.
High-tech solutions are already being incorporated into existing healthcare systems by several healthcare providers.
FiberSmart, a new technology that enables the visualization and analysis of long DNA fibers at high resolution, was recently introduced by Genomic Vision, a French biotechnology company that specializes in the development and commercialization of diagnostic solutions for genetic diseases and cancers.
Genomic Vision asserts that FiberSmart can enhance the precision and efficacy of genetic disease diagnosis and treatment, thereby reducing healthcare expenditures and enhancing patient outcomes.
Additionally, AI is being used to improve diagnosis accuracy and efficiency, discover novel therapies and treatments, and even anticipate and stop disease outbreaks.
The global artificial intelligence (AI) in the healthcare market is segmented into North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. From 2022 to 2030, North America commanded the highest market share of all regions. This is attributed to rising healthcare expenditures, expanding AI adoption across the care continuum, and expanding AI/ML implementation in the North American healthcare sector.
However, the Asia-Pacific region is anticipated to experience the fastest growth in the coming years due to favorable government initiatives, growing investments from venture capitalists and private investors, and growing advancements in healthcare infrastructure. The Asia-Pacific artificial intelligence in the healthcare market is also supported by the growing elderly population and the prevalence of chronic and infectious diseases in China, India, and other nations.
